Skip to Main Content

Paper Details

Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma.
Nat Commun
12
2022
KRAS, NR5A2, Oncogenic KRAS mutations, PROX1, cholangiocarcinoma, chr1q, colorectal adenocarcinoma, gene fusions, mPDAC, metastatic pancreatic ductal adenocarcinoma, patients
Author NameAffiliation
Steve E Kalloger
Steve E Kalloger
Gian Luca Negri
Gun Ho JangOntario Institute for Cancer Research
Robert E DenrocheOntario Institute for Cancer Research
Richard A Moore
Andrew J Mungall
Faiyaz NottaOntario Institute for Cancer Research
Julie M WilsonOntario Institute for Cancer Research
Oliver F BatheCummings School of Medicine, University of Calgary
Oliver F BatheCummings School of Medicine, University of Calgary
Steven GallingerOntario Institute for Cancer Research
Steven GallingerUniversity Health Network, University of Toronto
Janessa Laskin
Janessa Laskin
Marco A Marra
Marco A Marra
Steven J M Jones
Steven J M JonesUniversity of British Columbia
Steven J M Jones
Steven J M JonesUniversity of British Columbia
  • 1 - 21

Datasets

Release 1.2